<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ920310-0166</DOCNO><DOCID>920310-0166.</DOCID><HL>   Financing Business:   Intramed Laboratories Inc.</HL><DATE>03/10/92</DATE><SO>WALL STREET JOURNAL (J), NO PAGE CITATION</SO><MS>TECHNOLOGY (TEC)</MS><IN>INITIAL PUBLIC OFFERINGS (INI)ADVANCED TECHNOLOGY MEDICAL DEVICES (MDV)MEDICAL andamp; BIOLOGICAL TECHNOLOGY (MTC)STOCK AND BOND REGISTRATIONS, PRICINGS (REG)STOCK MARKET, OFFERINGS (STK)</IN><NS>INITIAL PUBLIC OFFERINGS (INI)BOND AND STOCK REGISTRATIONS AND PRICINGS (REG)STOCK MARKET NEWS (STK)</NS><RE>CALIFORNIA (CA)NORTH AMERICA (NME)PACIFIC RIM (PRM)UNITED STATES (US)</RE><LP>   INTRAMED LABORATORIES Inc. filed for a proposed initialpublic offering of 1,875,000 common shares to be pricedbetween $8 and $10 each via H.J. Meyers andamp; Co. The San Diegocompany develops and makes therapeutic devices for minimallyinvasive surgery, diagnosis and treatment monitoring.</LP><TEXT/></DOC>